Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals.

[1]  D. Hooper,et al.  New Plasmid-Mediated Quinolone Resistance Gene, qnrC, Found in a Clinical Isolate of Proteus mirabilis , 2009, Antimicrobial Agents and Chemotherapy.

[2]  P. Nordmann,et al.  Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. , 2009, Current medicinal chemistry.

[3]  F. Aarestrup,et al.  qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin , 2008, Antimicrobial Agents and Chemotherapy.

[4]  L. Martínez-Martínez,et al.  Detection of the Pandemic O25-ST131 Human Virulent Escherichia coli CTX-M-15-Producing Clone Harboring the qnrB2 and aac(6′)-Ib-cr Genes in a Dog , 2008, Antimicrobial Agents and Chemotherapy.

[5]  P. Nordmann,et al.  Plasmid-Mediated Quinolone Resistance Pump QepA2 in an Escherichia coli Isolate from France , 2008, Antimicrobial Agents and Chemotherapy.

[6]  Y. Carmeli,et al.  Plasmid-Mediated qnrB2 and Carbapenemase Gene blaKPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates , 2008, Antimicrobial Agents and Chemotherapy.

[7]  E. Cambau,et al.  Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. , 2008, The Journal of antimicrobial chemotherapy.

[8]  Y. Arakawa,et al.  Plasmid-Mediated qepA Gene among Escherichia coli Clinical Isolates from Japan , 2008, Antimicrobial Agents and Chemotherapy.

[9]  W. Shi,et al.  Prevalence and Expression of the Plasmid-Mediated Quinolone Resistance Determinant qnrA1 , 2007, Antimicrobial Agents and Chemotherapy.

[10]  P. Courvalin,et al.  Transferable Resistance to Aminoglycosides by Methylation of G1405 in 16S rRNA and to Hydrophilic Fluoroquinolones by QepA-Mediated Efflux in Escherichia coli , 2007, Antimicrobial Agents and Chemotherapy.

[11]  L. Martínez-Martínez,et al.  Mutant Prevention Concentrations of Fluoroquinolones for Enterobacteriaceae Expressing the Plasmid-Carried Quinolone Resistance Determinant qnrA1 , 2007, Antimicrobial Agents and Chemotherapy.

[12]  D. Trott,et al.  Identification of plasmid-mediated extended-spectrum and AmpC beta-lactamases in Enterobacter spp. isolated from dogs. , 2007, Journal of medical microbiology.

[13]  A. Robicsek,et al.  The worldwide emergence of plasmid-mediated quinolone resistance. , 2006, The Lancet. Infectious diseases.

[14]  A. Robicsek,et al.  Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme , 2006, Antimicrobial Agents and Chemotherapy.

[15]  A. Robicsek,et al.  qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States , 2006, Antimicrobial Agents and Chemotherapy.

[16]  P. Nordmann,et al.  Plasmid-mediated quinolone resistance in Australia. , 2006, Microbial drug resistance.

[17]  K. Hopkins,et al.  Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. , 2005, International journal of antimicrobial agents.

[18]  P. Tulkens,et al.  Quinolones in 2005: an update. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  G. Jacoby,et al.  Plasmid-Mediated Quinolone Resistance in Clinical Isolates of Escherichia coli from Shanghai, China , 2003, Antimicrobial Agents and Chemotherapy.

[20]  W. Fales,et al.  Trends in Fluoroquinolone Resistance of Bacteria Isolated from Canine Urinary Tracts , 2003, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[21]  F. Notka,et al.  Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae. , 2002, The Journal of antimicrobial chemotherapy.

[22]  L. Piddock,et al.  Quinolone resistance in Escherichia coli. , 2001, Veterinary research.

[23]  S. Levy,et al.  Ineffectiveness of Topoisomerase Mutations in Mediating Clinically Significant Fluoroquinolone Resistance inEscherichia coli in the Absence of the AcrAB Efflux Pump , 2000, Antimicrobial Agents and Chemotherapy.

[24]  G. Jacoby,et al.  Quinolone resistance from a transferable plasmid , 1998, The Lancet.

[25]  S. Levy,et al.  Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli , 1997, Journal of bacteriology.

[26]  M. Yasuda,et al.  Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae. , 1997, The Journal of antimicrobial chemotherapy.

[27]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[28]  J Ruiz,et al.  Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs , 1994, Antimicrobial Agents and Chemotherapy.

[29]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[30]  A. Robicsek,et al.  Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase , 2006, Nature Medicine.

[31]  Mingzhi Wang,et al.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli , 2006 .